OBJECTIVE: To assess the effect of sildenafil on superoxide formation and p47(phox) (the active subunit of NADPH oxidase) expression in cultured corpus cavernosal smooth muscle cells (CVSMCs). MATERIALS AND METHODS: CVSMCs derived from rabbit penis were incubated with U46619 (thromboxane A2 analogue) with or without sildenafil for 1 or 16 h at 37 degrees C. Superoxide dismutase-inhibitable superoxide formation was assessed using the reduction of ferricytochrome c measured spectrophotometrically, and gp47(phox) assessed using Western blot analysis. The role of NAD[P]H oxidase and cGMP was further studied by using specific inhibitors of each. RESULTS: Superoxide formation was significantly greater in cells incubated with U46619 after 1 and 16 h incubation than in controls, an effect blocked by NADP(H) oxidase inhibitors. These effects of U46619 were inhibited by sildenafil (1 and 10 nmol/L), which in turn were negated by the guanylyl cyclase inhibitor, ODQ; 10 nmol/L sildenafil inhibited p47phox expression induced by U46619. CONCLUSIONS: Sildenafil is a potent inhibitor of superoxide formation in CVSMCs. This effect is mediated through the inhibition of PDE-5 which in turn augments the inhibitory action of the NO-cGMP axis on NAD[P]H oxidase expression and activity. This mechanism constitutes a new pharmacological action of sildenafil, consolidates the potential role of superoxide in ED, and indicates that thromboxane A(2) may be an important mediator of intrapenile oxidative stress.
OBJECTIVE: To assess the effect of sildenafil on superoxide formation and p47(phox) (the active subunit of NADPH oxidase) expression in cultured corpus cavernosal smooth muscle cells (CVSMCs). MATERIALS AND METHODS: CVSMCs derived from rabbit penis were incubated with U46619 (thromboxane A2 analogue) with or without sildenafil for 1 or 16 h at 37 degrees C. Superoxide dismutase-inhibitable superoxide formation was assessed using the reduction of ferricytochrome c measured spectrophotometrically, and gp47(phox) assessed using Western blot analysis. The role of NAD[P]H oxidase and cGMP was further studied by using specific inhibitors of each. RESULTS:Superoxide formation was significantly greater in cells incubated with U46619 after 1 and 16 h incubation than in controls, an effect blocked by NADP(H) oxidase inhibitors. These effects of U46619 were inhibited by sildenafil (1 and 10 nmol/L), which in turn were negated by the guanylyl cyclase inhibitor, ODQ; 10 nmol/L sildenafil inhibited p47phox expression induced by U46619. CONCLUSIONS:Sildenafil is a potent inhibitor of superoxide formation in CVSMCs. This effect is mediated through the inhibition of PDE-5 which in turn augments the inhibitory action of the NO-cGMP axis on NAD[P]H oxidase expression and activity. This mechanism constitutes a new pharmacological action of sildenafil, consolidates the potential role of superoxide in ED, and indicates that thromboxane A(2) may be an important mediator of intrapenile oxidative stress.
Authors: S Muzaffar; N Shukla; M Bond; G Sala-Newby; G D Angelini; A C Newby; J Y Jeremy Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2008-04-16 Impact factor: 4.006
Authors: Biljana Musicki; Tongyun Liu; Gwen A Lagoda; Travis D Strong; Sena F Sezen; Justin M Johnson; Arthur L Burnett Journal: J Sex Med Date: 2010-09 Impact factor: 3.802
Authors: A Schäfer; D Fraccarollo; S Pförtsch; U Flierl; C Vogt; J Pfrang; A Kobsar; T Renné; M Eigenthaler; G Ertl; J Bauersachs Journal: Br J Pharmacol Date: 2007-09-24 Impact factor: 8.739
Authors: Maria A S Fernandes; Ricardo J F Marques; Joaquim A F Vicente; Maria S Santos; Pedro Monteiro; António J M Moreno; José B A Custódio Journal: Mol Cell Biochem Date: 2007-11-16 Impact factor: 3.396
Authors: Rita C Tostes; Fernando S Carneiro; Anthony J Lee; Fernanda R C Giachini; Romulo Leite; Yoichi Osawa; R Clinton Webb Journal: J Sex Med Date: 2008-03-04 Impact factor: 3.802
Authors: Matthias E Werner; Andrea L Meredith; Richard W Aldrich; Mark T Nelson Journal: Am J Physiol Regul Integr Comp Physiol Date: 2008-05-14 Impact factor: 3.619
Authors: Fábio H Silva; Serkan Karakus; Biljana Musicki; Hotaka Matsui; Trinity J Bivalacqua; Jean L Dos Santos; Fernando F Costa; Arthur L Burnett Journal: J Pharmacol Exp Ther Date: 2016-08-18 Impact factor: 4.030